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Abstract
The coxsackie- and adenovirus receptor (CAR) is a cell adhesion molecule predominantly associated with epithelial tight
junctions in adult tissues. CAR is also expressed in cardiomyocytes and essential for heart development up to embryonic day
11.5, but not thereafter. CAR is not expressed in vascular endothelial cells but was recently detected in neonatal lymphatic
vessels, suggesting that CAR could play a role in the development of the lymphatic system. To address this, we generated
mice carrying a conditional deletion of the CAR gene (Cxadr) and knocked out CAR in the mouse embryo at different time
points during post-cardiac development. Deletion of Cxadr from E12.5, but not from E13.5, resulted in subcutaneous edema,
hemorrhage and embryonic death. Subcutaneous lymphatic vessels were dilated and structurally abnormal with gaps and
holes present at lymphatic endothelial cell-cell junctions. Furthermore, lymphatic vessels were filled with erythrocytes
showing a defect in the separation between the blood and lymphatic systems. Regionally, erythrocytes leaked out into the
interstitium from leaky lymphatic vessels explaining the hemorrhage detected in CAR-deficient mouse embryos. The results
show that CAR plays an essential role in development of the lymphatic vasculature in the mouse embryo by promoting
appropriate formation of lymphatic endothelial cell-cell junctions.
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Introduction
The coxsackie- and adenovirus receptor (CAR) was originally
identified as a cellular receptor for coxsackie B viruses and type C
adenoviruses [1,2]. Structurally, CAR is related to the Cortical
Thymocyte marker in Xenopus (CTX) proteins of the large
immunoglobulin family, which also includes the junction adhesion
molecules (JAMs) [3], endothelial cell specific adhesion molecule
(ESAM) [4] and CAR-like membrane protein (CLMP) [5]. CAR is
highly expressed during development in the brain and in the heart,
but is rapidly downregulated after birth and thereafter predom-
inantly expressed in tight junctions of epithelial cells [6].
In the heart, CAR localizes to intercalated discs in cardiomy-
ocytes where it plays an essential role as CAR-deficient mouse
embryos die around E11.5-E13.5 due to cardiomyocyte dysfunc-
tion and heart failure [7,8]. Importantly, heart-specific deletion of
CAR after E11 does not result in a lethal phenotype indicating
that CAR is important for heart development only within a short
time frame and that CAR may be essential for the development of
other organ systems as well [9]. Recent data show that CAR is
expressed in human neonatal foreskin lymphatic endothelial cells,
where it localizes to cell-cell junctions [10]. In vitro studies showed
that CAR mediates adhesion between lymphatic endothelial cells
and also the capacity of these cells to migrate and form tubes.
However, it is not known whether CAR plays a role in the
development of the lymphatic system in vivo.
The lymphatic system maintains tissue homeostasis by draining
fluid from peripheral tissues to the circulation [11]. It is also
important for the absorption of lipids from the gastrointestinal
tract and for immune cell trafficking during inflammation.
Lymphatic dysfunction may lead to lymph edema, impaired
immunity and accumulation of subcutaneous fat. The lymphatic
system is also the primary route for tumor cell dissemination and
therefore plays an important role in cancer metastasis [12].
Development of the lymphatic vasculature begins at embryonic
day (E) 9.5–10.5 in mice, after the establishment of a functional
blood vasculature [13]. Distinct populations of cardinal vein
endothelial cells positive for vascular endothelial growth factor
receptor 3 (VEGFR-3), the lymphatic vessel hyaluronan receptor-
1 (LYVE-1), and the transcription factors SOX18 and PROX1,
commit to the lymphatic lineage and sprout to form lymph sacs in
response to VEGF-C. Lymphatic endothelial cells begin to express
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podoplanin, which promotes platelet aggregation and disconnec-
tion of lymphatic vessels from veins during embryonic develop-
ment [14]. Lymphatic vessels are formed by sprouting from the
lymph sacs and are subsequently remodeled into a lymphatic
vascular network consisting of blind-ended lymphatic capillaries
with specialized button-type junctions, supporting influx of fluid
and cells [15,16]. Collecting lymphatic vessels also acquire luminal
valves supporting transport of lymph without backflow [13,17].
EphrinB2, angiopoietin-2 (Ang-2) and the transcription factor
FOXC2 are important for remodeling of the lymphatic vascula-
ture [18,19,20]. FOXC2 cooperates with the nuclear factor of
activated T cells (NFATc)-1 downstream of VEGFR-3 to control
the expression of a set of genes required for the differentiation of
lymphatic vessels but is downregulated during maturation of
collecting lymphatic vessels, leading to decreased expression of
PROX1, VEGFR-3 and LYVE-1 at later stages [21]. The
lymphatic vasculature develops and matures during the postnatal
period and in adult tissues, growth of lymphatic vessels is normally
restricted to pathological conditions characterized by tissue
remodeling, such as cancer and chronic inflammation.
We wanted to elucidate whether CAR could play a role in
development of the lymphatic system in the mouse. To study this
we generated tamoxifen-inducible CAR deficient mice, which
allowed us to delete Cxadr at different time points after E11, when
CAR expression in cardiomyocytes was not essential for heart
development. The results demonstrate an essential role of CAR for
the development of the lymphatic vasculature.
Results
CAR-deficiency during a critical time window of mouse
development leads to subcutaneous edema and
hemorrhage
Mice carrying floxed Cxadr alleles (CxadrFlox/Flox) (F/F) were
generated, as recently described [22]. To induce recombination
between the loxP sites in mouse embryos, F/F females were
crossed with F/F;Cre males. Additional breeding created the
mouse line F/F;Cre that was backcrossed three times onto C57Bl/
6J and then used for experiments. Starting at E12.5, pregnant
females were given tamoxifen by intraperitoneal injections on two
consecutive days. Animals were sacrificed at different time-points
from E14.5 to E18.5. Genotyping of genomic DNA isolated from
the tail demonstrated an equal distribution of F/F and F/F;Cre
embryos, as expected, and an efficient Cre-mediated recombina-
tion in F/F;Cre embryos (conditional knockout, cKO), with none in
F/F littermate controls (ctrl) [22]. Western blotting analysis of
protein extracts from decapitated embryos demonstrated signifi-
cantly reduced CAR levels in cKO embryos compared to ctrl
embryos at E14.5 and E15.5 (Fig. 1A). Importantly, CAR protein
levels in tamoxifen-treated F/F and +/+;Cre (mice carrying wild
type Cxadr alleles) control embryos were indistinguishable from
wildtype embryos demonstrating that neither tamoxifen treatment
itself nor the presence of the Cre protein without loxP
recombination sites could disrupt expression from Cxadr [22].
Gross differences between CAR cKO embryos compared to
control embryos could be seen from E16.5 (Fig. 1B and Table 1).
Both male and female cKO embryos were smaller than their
littermate controls and displayed macroscopic hemorrhage and
subcutaneous edema. Table 1 shows the proportion of embryos
with visible, phenotypic changes. Genotyping of the two litters
examined at E18.5 demonstrated that none of the living embryos
were cKO embryos. At this timepoint most cKO embryos were
already in advanced states of resorption, which made analysis of
edema and hemorrhage very difficult. In Table 1 we therefore
choosed to exclude these embryos and include only embryos with
clear visible, phenotypic changes. Microscopic inspection of the
limbs indicated that most cKO embryos did not develop beyond
E17.5 (data not shown). Histological analyses revealed subcutane-
ous edema in cKO embryos starting from E15.5 (Fig. 1C). No
signs of cardiac dilation or structural abnormalities in the heart
similar to those described in hearts of CAR2/2 mice before E11.5
[8] [7], or abnormalities in any other tissues, were observed. No
abnormal phenotype was observed in tamoxifen-treated hetero-
zygous F/+;Cre animals or in +/+;Cre controls (data not shown).
Administration of tamoxifen to F/F;Cre mice from E13.5 and
onwards did not result in edema formation or hemorrhage, and
was not lethal (data not shown). Together with previous data
showing that heart-specific deletion of CAR after E11 is not lethal,
our results indicated that CAR plays an essential role for the
formation of other parts of the cardiovascular system during a
critical time period of development.
CAR is expressed in lymphatic but not vascular
endothelial cells during mouse development
To investigate this further we performed immunofluorescent
staining of whole embryos, or whole-mount skin preparations, to
study the expression of CAR in subcutaneous blood and lymphatic
vessels of embryos at different stages of development. Blood and
lymphatic vessels were visualized and distinguished from each
other through their well-established expression of CD31, which is
high in blood vessels (CD31high) and low in lymphatic vessels
(CD31low), and LYVE-1, which is expressed in lymphatic vessels
(LYVE-1pos) but not in blood vessels (LYVE-1neg).
CD31high/LYVE-1neg blood vessels were present in the skin at
all time points between E13.5 and E16.5 (Fig. S1). In comparison,
CD31low/LYVE-1pos lymphatic vessels were almost absent in the
skin of E13.5 control embryos but were present from E14.5 and
onwards, demonstrating that the lymphatic vasculature of the skin
was being formed during this time window. No expression of CAR
was detected in blood vessels at any of the time points (Figs. 2A,
and S2). In contrast, positive CAR staining was detected in
subcutaneous lymphatic vessels at E.14.5, E.15.5, and E.16.5
(Figs. 2A, and S2). Similar to the distribution in epithelial cells,
CAR localized to cell-cell junctions in lymphatic endothelial cells,
where it partially co-localized with CD31 and LYVE-1 (Fig. 2B).
No CAR staining was found in the skin of E13.5 control embryos
(Fig. S2). In the skin of adult mice, CAR expression was readily
detected in the epithelium, but absent in the lymphatic vasculature
(Fig. S2). These results are in agreement with our previous studies
showing lack of CAR expression in lymphatic vessels of adult mice
[23].
The results demonstrated that CAR is expressed at lymphatic
endothelial cell junctions during the initial phase of lymphatic
vessel development. However, as the lymphatic system is
remodeled into a hierarchical network of lymphatic vessels,
CAR expression declines to undetectable levels. Thus, the
formation of the lymphatic system and the expression of CAR in
lymphatic endothelial cells coincided with a period of mouse
development between E.12.5–E16-5, when mouse embryos were
sensitive to CAR deficiency. Together, this suggested that the
subcutaneous edema observed in the cKO embryos was due to
impaired tissue homeostasis caused by non-existing or dysfunc-
tional lymphatic vessels.
Role of CAR in Development of the Lymphatic System
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Deformed and dilated lymphatic vessels in CAR-deficient
mouse embryos
Immunohistochemical staining for LYVE-1 in embryo sections
revealed no major differences in the distribution of lymphatic
vessels in cKO versus control embryos at E16.5 (data not shown).
Thus, lymphatic vessels were not absent in CAR-deficient
embryos. Imaging of whole-mount skin preparations stained by
immunofluorescence and analyzed by high-resolution confocal
microscopy revealed no detectable expression of CAR in
lymphatic vessels of the CAR cKO embryos, thus verifying that
tamoxifen-mediated deletion of the CAR gene was efficient in
lymphatic endothelial cells (Fig. 2C).
Lymphatic vessels in the skin of cKO embryos were structurally
abnormal and dilated compared to lymphatic vessels in control
embryos (Fig. 3A and Fig. 2C (compare to Fig. 2A)). Quantifica-
tion of vessel size revealed that the average lymphatic vessel
diameter was more than doubled in cKO embryos compared to
littermate controls (Fig. 3B). Analyses performed at E14.5 and
E15.5 showed similar defects in cKO embryos thus demonstrating
that lymph vessel defects preceded the observed subcutaneous
edema (Fig. S3). Blood vessels analyzed at the same embryonic age
appeared normal and were not enlarged (Fig. 3C,D). These
findings are consistent with those from a previous study, in which
CAR-deficiency was shown to affect lymphatic tube formation in
vitro [10].
Impaired formation of lymphatic endothelial cell-cell
junctions in CAR-deficient mice
More detailed analysis of LYVE-1 stained whole-mount skin
preparations from E16.5 cKO embryos revealed the presence of
gaps and holes at or close to junctions between endothelial cells of
subcutaneous lymphatic vessels (Fig. 4A, B). Such gaps were not
identified in lymphatic vessels from control embryos (Fig. S4). In
some areas, larger wholes were found in lymphatic vessels from
CAR cKO embryos (Fig. 5C). These results indicated that CAR-
deficiency resulted in impaired cell-cell adhesion and formation of
junctions between lymphatic endothelial cells.
Figure 1. CAR deficiency in mouse embryos after heart development causes subcutaneous edema, hemorrhage and lethality. (A)
Western blot analysis of CAR protein levels in E14.5 and E15.5 embryos from F/F;Cre (cKO, n = 3) and littermate F/F control (ctrl, n = 3) animals from
two litters after administration of tamoxifen at E12.5. Primary CAR antibody was RP 291. An antibody against calnexin was used as a loading control.
(B) Macroscopic images of E16.5 embryos given tamoxifen at E12.5 showing subcutaneous edema and hemorrhage in cKO (n= 12) embryos but not
in littermate F/F (n = 18) control embryos (ctrl), which appeared normal. Embryos were from 5 litters. Images were taken with a 46 objective. (C)
Histological analysis of transverse sections of E16.5 embryos given tamoxifen at E12.5 showing subcutaneous edema in tamoxifen-treated cKO (n= 3)
embryos while the littermate F/F controls (ctrl, n = 3) were normal. Embryos were from 3 litters. Images were taken with a 206 objective. Scale
bar = 50 mm.
doi:10.1371/journal.pone.0037523.g001
Table 1. The proportion of embryos with macroscopic
phenotypic changes following tamoxifen administration at
E12.5.
Embryonic day (E) ctrl cKO
n % n %
E16.5 am 0 (10) 0 0 (12) 0
E16.5 pm 0 (18) 0 8 (20) 40
E17.5 0 (11) 0 10 (17) 59
E18.5 0 (7) 0 2 (2) 100
Embryonic day (E) indicate day of analysis. The morning and afternoon of E16.5
is indicated as am and pm, respectively. Ctrl and cKO are tamoxifen-treated
embryos with genotypes F/F and F/F;Cre, respectively. Animals with
macroscopic phenotypic changes are indicated as number of animals (n) as well
as % of animals. The total number of embryos analyzed is indicated within
brackets. Phenotypic changes include edema, hemorrhage and reduced crown-
rump length.
doi:10.1371/journal.pone.0037523.t001
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To further analyze the integrity of lymphatic vessels in cKO
embryos at the ultrastructural level, skin tissues from cKO and
control embryos at E16.5 were analyzed by transmission electron
microscopy. In control embryos, lymphatic endothelial cells were
connected to each other forming an intact lining around the entire
lumen of the lymphatic vessels (Fig. 4C). In cKO embryos,
lymphatic vessels appeared damaged and necrotic endothelial cells
with small nuclei were frequently observed. Regions of the luminal
surface of lymphatic vessels were devoid of lymphatic endothelial
cells.
Together, these results indicated that CAR is important for the
formation of junctions between lymphatic endothelial cells. Since
no macroscopic edema or defects in lymphatic development were
observed when CAR knockdown was induced at later time points
(from E13.5), and since CAR expression was high in developing
lymphatic vessels but low in maturating vessels we conclude that
CAR plays an essential role for the formation of the lymphatic
system during a critical developmental period when the lymphatic
system is being formed.
Impaired separation between blood and lymphatic
vessels in CAR-deficient mouse embryos
While leaky lymphatic vessels could explain the subcutaneous
edema observed in the cKO embryos the mechanism involved in
causing hemorrhage remained unclear. A critical part of the
formation of the lymphatic system is the separation between the
blood and the lymphatic vasculature to create two separate
circulation systems. To investigate whether incomplete separation
between blood and lymphatic vessels contributed to the phenotype
of cKO embryos we stained whole-mount skin preparations of
E16.5 embryos with the erythrocyte marker TER-119. As
expected, ubiquitous TER-119 staining was seen in blood vessels
but not in lymphatic vessels in control animals (Fig. 5A). However,
in the cKO embryos, TER-119 staining was frequently observed
in lymphatic vessels demonstrating the presence of erythrocytes in
the lymphatic system (Fig. 5B). Blood-filled lymphatic vessels were
often found in close proximity to blood vessels. A close inspection
of blood-filled lymphatic vessels revealed interstitial leakage of
Figure 2. CAR is expressed in lymphatic endothelial cells during mouse development and localizes to cell-cell junctions. Confocal
images of whole-mount skin preparations from wildtype (A, B) (n = 3) and cKO (C) (n = 3) E16.5 embryos stained by immunofluorescence with the
antibodies rabbit anti-CAR IG1 (green), hamster anti CD31 (red) and rat anti LYVE-1 (purple) to visualize CAR expression in blood vessels
(CD31highLYVE-1neg) and lymphatic vessels (CD31lowLYVE-1pos). Animals were from 3 different litters (A) Low magnification images showing CAR
expression in lymphatic vessels but not in blood vessels. Scale bar = 50 mm (B). High-magnification images showing distribution and partial co-
localization of CAR with CD31, and LYVE-1 at lymphatic endothelial cell-cell junctions (arrows). Scale bar = 50 mm. (C) Low magnification images
showing efficient downregulation of CAR in lymphatic vessels of cKO embryos. Scale bar = 50 mm.
doi:10.1371/journal.pone.0037523.g002
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erythrocytes at regions of lymphatic vessels where gaps were
present, thus forming regions of hemorrhage (Fig. 5C).
These results showed that CAR expression at lymphatic
endothelial cell-cell junctions is essential for proper formation
and function of lymphatic vessels during development and also, for
complete separation between the blood and the lymphatic
vasculature.
Discussion
The aim of this study was to analyze the role of CAR in embryo
development after E11.5. For this purpose we constructed a
conditional knockout (cKO) mouse strain, in which the CAR gene
was deleted in all embryonic tissues following intraperitoneal
administration of tamoxifen to pregnant females. We found that
deletion of the CAR gene from E12.5, at a time point when CAR
is no longer essential for cardiac development [9], caused
subcutaneous edema, hemorrhage, and embryonic death. This
suggested that CAR was important for the development of
additional parts of the cardiovascular system.
Similar to previous reports, CAR expression was not found in
blood vessels at any time point of development. Subcutaneous
blood vessels appeared structurally normal in CAR-deficient
embryos displaying subcutaneous edema and hemorrhage.
Together, these results suggested that CAR-deficiency did not
primarily affect blood vessels. In contrast, the observed subcuta-
neous edema and hemorrhage in CAR-deficient mouse embryos
were associated with the presence of structurally and functionally
abnormal lymphatic vessels.
Lymphatic vessels in CAR-deficient embryos were dilated and
contained gaps and holes at junctions between lymphatic
endothelial cells. Thus, we conclude that CAR plays an important
role for proper formation of cell-cell junctions between lymphatic
endothelial cells at a time point when lymphatic vessels are
formed. This is supported by recent in vitro data showing that
siRNA-mediated knockdown of CAR in cultured lymphatic
endothelial cells results in impaired formation of intercellular
junctions and increased permeability across the endothelial cell
layer [10]. The results showing the presence of larger wholes with
necrotic lymphatic endothelial cells in areas of lymphatic vessels
from the CAR cKO embryos could reflect that improper
formation of tight junctions may lead to degeneration and loss
of lymphatic endothelial cells. Interestingly, knockdown of CAR
from E13.5 was not embryonic lethal. In addition, CAR
expression was not detected in lymphatic endothelial cells in adult
mice. Thus, CAR seems to play an essential role for lymphatic
development during a developmental period when junctions
between lymphatic endothelial cells are formed. However, as
interactions between lymphatic endothelial cells are stabilized
during the formation a fully matured lymphatic network, CAR is
no longer needed. It will be of interest for the future to analyze
whether CAR is upregulated and important for the formation of
new lymphatic vessels during pathological lymphangiogenesis,
which frequently is seen both in tumors and in conditions of
chronic inflammation.
The hemorrhage observed in CAR deficient mouse embryos
was initially difficult to explain since blood vessels appeared
normal. However, as we discovered blood circulating inside and
leaking out from defective lymphatic vessels we concluded this to
be a likely mechanistic explanation for the hemorrhage. The more
precise mechanism by which CAR mediates separation between
the blood and lymphatic systems remains to be determined. It
could be that CAR-mediated formation of junctions between
lymphatic endothelial cells is important for complete closure
Figure 3. Lymphatic vessels of CAR deficient mouse embryos are structurally abnormal. (A, C) Confocal immunofluorescence images of
whole-mount skin preparations from cKO (n= 5) and littermate F/F controls (ctrl, n = 4) at E16.5 co-stained with the antibodies rabbit anti-LYVE-1
(green) and hamster anti-CD31 (red) to visualize lymphatic vessels (A) and blood vessels (C), respectively. Embryos were from 2 litters. Scale
bar = 50 mm. (B, D) Measure of vessel diameter. Data is presented as means 6 SEM with at least four to six mice per group. (A) Immunofluorescence
images showing dilated lymphatic vessels in cKO compared to ctrl embryos. (B) Bar graph showing significantly increased average diameter of
subcutaneous lymphatic vessels in cKO versus F/F control (ctrl) embryos at E16.5. P,0.001. (C) Immunofluorescence images showing no differences in
blood vessels in cKO compared to ctrl embryos. (D) Bar graph showing no significant differences in average diameter of subcutaneous blood vessels
in cKO versus F/F control (ctrl) embryos at E16.5. P = 0.76.
doi:10.1371/journal.pone.0037523.g003
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between the systems. On the other hand, it could also relate to a
yet undiscovered role of CAR. Similar to our results, incomplete
separation of the vascular and lymphatic systems was previously
reported in mice disrupted of Syk, SLP-76, kindlin-3 or podoplanin,
genes required for the function of platelets [13,14]. Among
proteins encoded by these genes, podoplanin is also, similar to
CAR, a transmembrane protein expressed in lymphatic, but not
vascular endothelial cells. Interaction between lymphatic endo-
thelial podoplanin and circulating platelets was shown to activate
and aggregate platelets leading to closure of the junction between
the cardinal vein and the developing lymph sacs [14]. Recently, it
was reported that CAR is expressed on human platelets and
Figure 4. Lymphatic vessels of CAR deficient mouse embryos display endothelial gaps. (A, B) High-resolution confocal images of whole-
mount skin preparations from E16.5 cKO (n= 3) and littermate F/F control (ctrl, n = 3) embryos stained in three independent experiments by
immunofluorescence with antibodies to visualize lymphatic vessels (LYVE-1, green) and junctions between lymphatic endothelial cells (CD31/VE-
cadherin, red). DAPI was used to visualize nuclei (blue). (A) Immunofluorescence image showing a dilated LYVE-I positive lymphatic vessel in an E16.5
cKO embryo (left). Gaps between endothelial cells are present and even more visible at higher magnification (arrows in right image, which is a
magnification of the white box outlined in the left image). Primary antibody was rat anti-LYVE-1. Scale bar = 50 mm. (B) Top panel: High-magnification
images of a dilated LYVE-I positive lymphatic vessel from an E16.5 cKO embryo showing the presence of lymphatic endothelial gaps (arrows) at, or
close to, cell-cell junctions visualized by co-staining with antibodies against CD31 (red, middle image) or VE-cadherin (red, right image). Bottom panel:
no gaps were present in similarly stained F/F littermate controls (ctrl). Primary antibodies were rabbit anti-LYVE-1, hamster anti CD31 and rat anti VE-
cadherin. Scale bar = 150 mm. (C) Transmission electron microscopy (TEM) images of subcutaneous lymphatic vessels (L) in E16.5 cKO (n= 4) and
littermate F/F control (ctrl, n = 4) embryos. Embryos were from two litters. In ctrl embryos, lymphatic endothelial cells with clearly visible nuclei (N)
formed an intact lining around the entire lumen of the lymphatic vessels. In cKO embryos, lymphatic endothelial cell nuclei were smaller and the cells
appeared locally damaged (arrow) and did not form an intact lining of the vessel lumen. Regions of the luminal surface were devoid of lymphatic
endothelial cells (arrowheads). Scale bars = 10 mm (left and middle images), 5 mm (right image).
doi:10.1371/journal.pone.0037523.g004
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involved in mediating adenovirus attachment to these cells [24]. It
is therefore tempting to speculate that CAR, similar to
podoplanin, is involved in interactions between lymphatic
endothelial cells and platelets and that failure of such interactions
to form represent a mechanism of the incomplete separation
between the blood and lymphatic systems in cKO embryos.
However, to completely elucidate this would require cell-type
specific deletion or rescue of CAR in lymphatic endothelial cells
and platelets.
In summary, this study demonstrates an essential and previously
undiscovered role for CAR in the development of the lymphatic
system in the mouse. CAR deficiency during a critical time
window between E12.5–E15.5 leads to formation of structurally
abnormal and functionally impaired lymphatic vessels. The
mechanism involves incomplete formation of lymphatic endothe-
lial cell-cell junctions and as a result, failure of these cells to
interact with each other. In addition, CAR is required for proper
separation of the blood and lymphatic vasculature, and CAR
deficiency during this critical time window leads to ectopic blood
flow in the lymphatic system, edema and hemorrhage due to leaky
lymphatic vessels. Based on our data, recent results showing that
CAR is expressed in platelets [24], and the discovery that platelets
play a critical role in the separation between the blood and
lymphatic vasculature (reviewed in [25]), it is possible that this
separation process requires CAR-mediated interactions between
lymphatic endothelial cells and platelets.
Future studies should give further insights into the molecular
and cellular processes involved, as well as possible links to human
disease.
Materials and Methods
Ethics Statement
All animal experiments were approved by the animal ethical
committee and performed in accordance with its regulations.
Figure 5. CAR deficiency during mouse development causes incomplete separation of the blood and lymphatic systems. (A–C)
Confocal images of whole-mount skin preparations from E16.5 cKO (n = 3) and littermate F/F control (ctrl, n = 3) embryos stained in three
independent experiments by immunofluorescence with rat anti-TER 119 (TER, green) to visualize erythrocytes, and the vascular markers hamster anti-
CD31 (red) and rabbit anti-LYVE-1 (purple) to visualize blood vessels (CD31highLYVE-1neg) and lymphatic vessels (CD31lowLYVE-1pos). Scale
bar = 50 mm. (A, B) Images showing staining for TER in blood but not in lymphatic vessels in ctrl embryos (A), and staining for TER in dilated lymphatic
vessels in cKO embryos (B). Lower panels show z projections of the upper images at levels indicated by the white lines. (C) Images showing leakage of
TER-positive erythrocytes from dilated lymphatic vessels in cKO but not in ctrl embryos.
doi:10.1371/journal.pone.0037523.g005
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Generation of CAR deficient mice and genotyping
Floxed mice (F/F) harboring two loxP sites flanking Cxadr exon-
2 were generated at the MCI/ICS (Mouse Clinical Institute -
Institut Clinique de la Souris) in France; as described [22]. F/F
mice were then crossed with the transgenic mouse line B6.Cg-Tg
(CreEsr1)5 AmC/J (purchased from The Jackson Laboratory,
stock number 004682) expressing a tamoxifen-inducible Cre-
ERTM fusion protein under the control of a chicken ß actin/
cytomegalovirus (CMV) promoter [26]. Additional breeding
created the mouse line F/F;Cre that was backcrossed three times
onto C57Bl/6J and then used for experiments. PCR was used for
genotyping as described in [22].
Nomenclature
The following nomenclature is used for mice throughout the
paper. +/+ animals are wt C57Bl/6J mice, cKO are tamoxifen-
treated animals with the genotype F/F;Cre, ctrl are control animals
with genotype +/+ (wildtype) or F/F as indicated in the text, +/
+;Cre animals express the Cre recombinase but do not contain any
loxP sites. CAR and Cxadr is used throughout the paper and refers
to the protein and the Cxadr gene, respectively.
Animal procedures
Embryos older than E11 were sacrificed by decapitation due to
ethical considerations. The embryonic age was determined such
that the day of the vaginal plug was E 0.5. Tamoxifen (Sigma T-
5648) was dissolved in corn oil (Sigma C-8267) to a final
concentration of 10 mg/ml by vigorous shaking at 45uC for
2 hours. Tamoxifen was prepared fresh every week. Timed
plugged females were injected intraperitoneally with 2 mg
tamoxifen/40 g mice for two consecutive days at E12.5 and E13.5.
Antibodies
Primary antibodies used for immunofluorescence staining were;
CAR: rabbit anti-CAR RP 291 [23], rabbit anti-CAR IG1 [23];
blood and/or lymphatic vessels: hamster anti–CD31 (clone 2H8;
Chemicon), rabbit anti-LYVE-1 (Abcam), rat anti-LYVE-1 (Novus
Biologicals); adherens junctions: rat anti-VE-cadherin (clone
BV13, a kind gift to JF from E. Dejana, FIRC Institute, Milan,
Italy); erythrocytes: rat anti-TER119 (eBioscience). Wholemount
tissues were mounted in Vectashield mounting media with DAPI
(Vectalabs). Primary antibodies used for Western analyses were
rabbit anti-CAR RP 291 [23] and rabbit anti-calnexin [27]. FITC,
Cy3, or Cy5-labelled secondary antibodies for immunofluores-
cence were from Jackson ImmunoResearch Laboratories, and
secondary antibody for Western analysis was HRP-labeled donkey
anti-rabbit Ig (NA934V, GE healthcare, UK).
Western blotting
Whole embryo without the head was homogenized in lysis
buffer (50 mmol/L Tris-HCl (pH 7.5), 137 mmol/L NaCl, 0.5%
Triton X-100, and EDTA-free 16 complete protease inhibitor
from Roche Molecular Biochemicals) on ice, sonicated, and
incubated on ice for 20 min before centrifugation at maximum
speed in an Eppendorf centrifuge (Hamburg, Germany) at +4uC
for 15 min. The lysate was removed and run on a 10% SDS-
PAGE gel under reducing conditions, and transferred to
PROTRAN nitrocellulose transfer membrane (Schleicher &
Schuell, Dassel, Germany). Membranes were incubated in
blocking buffer (16 PBS with 0.1% Tween 20 and 5% dry milk)
at room temperature and then incubated with primary and
secondary antibody diluted in blocking buffer. Peroxidase activity
was detected using enhanced chemiluminescence and Hyperfilm
ECL (Amersham Biosciences).
Whole mount imaging and immunofluorescence
analyses
Pregnant mice were sacrificed and embryos were taken out at
day E.14.5, E15.5, and E16.5. The dorsal skin of embryos was
excised. For adult skin whole-mount, hair at the back of the mice
was shaved prior to excision of the dorsal skin. Skin was immersed
in 4% paraformaldehyde in PBS (pH 7.4) for 3 hours at room
temperature. Skin was washed with PBS and stained with primary
and secondary antibodies diluted in incubation buffer (0.3%
Triton X-100, 0.2% bovine serum albumin, 5% normal goat
serum and 0.1% sodium azide). Specimens were mounted in
Vectashield mounting media with DAPI (Vectalabs) and visualized
with confocal microscope (LSM-700; Carl Zeiss Microimaging,
Inc) using LSM Image Examiner.
Histological analysis of mouse tissues
Pregnant mice were sacrificed and embryos were dissected and
fixed in Bouin’s solution (Sigma HT10132) at room temperature
overnight. Next day the embryos were washed with 70% ethanol
several times and embedded in paraffin, sectioned and stained
with hematoxylin and eosin according to standard procedures.
Light microscopy was performed on a Nikon Eclipse 800;
TEKNO microscope. A pathologist examined tissues and evalu-
ated phenotypic abnormalities in tissues including the heart.
Measure of vessel diameter
Images of whole mount skin preparations from E16.5 cKO and
littermate F/F control (ctrl) embryos stained by immunofluores-
cence with antibodies against CD31 and LYVE-1 were taken
using a Zeiss LSM-700 confocal microscope. Blood and lymphatic
vessels were identified as CD31high/LYVE-1neg and CD31low/
LYVE-1pos, respectively. Images were taken from three random
areas of four cKO and six F/F control animals and imported into
the ImageJ software (http://rsb.info.nih.gov/ij) for measurements.
Measurement of the diameter of blood vessels was based on images
taken with a 206objective while measurement of the diameter of
lymphatic vessels was based on 106 objective. The average
diameter of blood and lymphatic vessels diameters was calculated
from the individual measurements.
Statistics
Data were presented as means 6 SEM with at least four to six
mice per group. Statistical analyses were determined by using
Student’s t test. P,0.05 considered as significant.
Transmission electron microscopy (TEM)
Skin tissue was dissected and small pieces were fixed in 2%
glutaraldehyde +0.5% paraformaldehyde in 0.1 mol/L sodiumca-
codylate buffer containing 0.1 mol/L sucrose and 3 mmol/L
CaCl2, pH 7.4 at room temperature for 30 min followed by
24 hours at 4uC. Specimens were rinsed in 0.15 mol/L sodium-
cacodylate buffer containing 3 mmol/L CaCl2, pH 7.4 postfixed
in 2% osmium tetroxide in 0.07 mol/L sodiumcacodylate buffer
containing 1.5 mmol/L CaCl2, pH 7.4 at 4uC for 2 hour,
dehydrated in ethanol followed by acetone and embedded in
LX-112 (Ladd, Burlington, Vermont, USA). Semithin sections
were cut and stained with toludinblue and used for light
microscopic analysis. Ultrathin section (approximately 40–
50 nm) were cut and contrasted with uranyl acetate followed by
lead citrate and examined in a Leo 906 transmission electron
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microscope at 80 kV. Digital images were taken by using a
Morada digital camera (Soft Imaging System, GmbH, Mu¨nster,
Germany). A pathologist examined tissues and evaluated structural
abnormalities of tissues including the heart.
Supporting Information
Figure S1 Subcutaneous lymphatic vessels are formed
during a time period of mouse development between
E13.5 and E16.5. Confocal images of whole-mount skin
preparations from wildtype mouse embryos (n = 4) of ages
E13.5, E14.5, E15.5, and E16.5 stained by immunofluorescence
with antibodies hamster anti-CD31 (red) and rat anti LYVE-1
(purple) to visualize blood vessels (CD31highLYVE-1neg) and
lymphatic vessels (CD31lowLYVE-1pos). Blood vessels were
detected at all embryonic ages and gradually increased in numbers
from E13.5 to E16.5. Lymphatic vessels were almost completely
absent at E13.5, but were detected and increased in numbers from
E14.5 and onwards. Scale bar = 50 mm.
(TIFF)
Figure S2 CAR expression in lymphatic vessels is
restricted to a period during development. Confocal
immunofluorescence images of whole-mount skin preparations
from wild-type embryos at E13.5, E14.5 and E15.5, and from
adult mice. CAR expression (green) was readily detected in
lymphatic vessels (purple, CD31lowLYVE-1pos) but not in blood
vessels (red, CD31highLYVE-1neg) at E14.5 and E15.5. CAR
expression in adult mice was clearly detected in the skin
epithelium, but not in lymphatic vessels. Scale bar = 50 mm.
(TIFF)
Figure S3 Structurally abnormal lymphatic vessels in
CAR deficient embryos at E14.5 and E15.5. High-
resolution confocal images of whole-mount skin preparations from
CAR cKO and littermate F/F controls (ctrl) at E14.5 and E15.5
stained by immunofluorescence for LYVE-1 (green). Abnormal
lymphatic vessels are seen in cKO embryos but not in controls at
both time points. Scale bar = 50 mm.
(TIFF)
Figure S4 Lymphatic vessels of E16.5 ctrl embryos have
no endothelial gaps. High-resolution confocal images of whole-
mount skin preparations from E16.5 F/F control embryos stained
by immunofluorescence for LYVE-1 (green). DAPI was used to
visualize nuclei (blue). No endothelial gaps were present in
lymphatic vessels of ctrl embryos. Scale bar = 150 mm.
(TIFF)
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